Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Study sponsor: NovoCure GmbH
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-11-29Actual
Enrollment · participants298Actual
Source updated2025-10-31Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.